H19 in Acute Lymphoblastic Leukemia.
NCT05943093 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2023-07-13
Summary
* Study the expression level of H19 gene in the samples from ALL patients by real-time PCR.
* Correlate the expression level of H19 gene with the clinical presentation and laboratory data of those patients.
Conditions
- Acute Lymphoid Leukemia
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 2 Months
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-31
- Primary Completion
- 2025-07-31
- Completion
- 2025-08-31
More Related Trials
-
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT01251159 ·Status: COMPLETED
-
Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study.
NCT04182074 ·Status: COMPLETED
-
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
NCT01089907 ·Status: UNKNOWN
-
Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
NCT05439889 ·Status: RECRUITING
-
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia
NCT01229124 ·Status: COMPLETED
-
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
NCT01819792 ·Status: COMPLETED ·Phase: PHASE4
-
Alternative Splicing and Leukemia Initiating Cells
NCT03156933 ·Status: UNKNOWN
-
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01298414 ·Status: COMPLETED
-
Study of miRNA-155 in Acute Leukemia
NCT05809050 ·Status: UNKNOWN
-
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
NCT07074496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy
NCT03889951 ·Status: UNKNOWN
-
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL
NCT06919393 ·Status: RECRUITING
-
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
NCT03594149 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01229956 ·Status: COMPLETED
-
Study of Bone Marrow Samples From Patients With Acute Leukemia
NCT00897559 ·Status: COMPLETED
-
Assesment of JL1 Expression in Acute Leukemia
NCT04554381 ·Status: UNKNOWN ·Phase: PHASE1
-
Metabolism Des LAM
NCT02176109 ·Status: UNKNOWN
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
NCT01057199 ·Status: COMPLETED
-
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
NCT06536452 ·Status: RECRUITING
-
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
NCT03123887 ·Status: COMPLETED
-
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
NCT01380587 ·Status: COMPLETED
-
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT05241093 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
NCT05345938 ·Status: TERMINATED ·Phase: PHASE1/PHASE2